Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer

NCT00036556 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
941
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott